ALPA · Alpa Laboratories Limited · Financials
Volume · Nov 13
117
Avg daily vol (3M)
4171
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
1.06B
-5.9%
FY2026
Net Income
150.1M
FY2026
Operating Cash Flow
99.5M
+41%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|---|---|
| INR | 1.11B | 1.06B | 1.12B | 1.09B | 924.36M | 1.12B | 975.54M | 859.69M |
| INR | 22.59M | 20.92M | 22.02M | 19.55M | 13.25M | 16.57M | 12.29M | 31.65M |
| INR | 3.21M | 2.58M | 2.32M | 3.59M | 2.23M | 2.43M | 779K | 1.96M |
| INR | 59.1M | 166.97M | 256.67M | 206.82M | 159.4M | 195.62M | 107.82M | 29.08M |
| INR | 15.32M | 16.87M | 61.64M | 39.06M | 33.08M | 54.7M | 35.38M | 10.54M |
| INR | 13.83M | 150.1M | 0 | 167.77M | 0 | 0 | 0 | 18.53M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2026: 0 in dividends.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.